Skip to main content
. 2019 Jan 1;8(1):363–373. doi: 10.1002/cam4.1895

Table 1.

Descriptive summary of selected studies (1980‐2018)

Author Sample Intervention Duration Outcome
No. of patients in I and C Type and stage of cancer Age, y (M ± SD or %) Married (%) Type Format Dose (h) Intervention Follow‐up (M) Survival = HR (95% Cl)
Spiegel (1989) I = 50
C = 36
Breast, metastatic 54.6 ± 10.2 62.5 SEGT Group 78 1 y 10 y 0.51 (0.31, 0.83)
Cunningham (1998) I = 30
C = 36
Breast, metastatic 49.5 ± 13 74 CBT Group 84 35 wk 5 y 0.76 (0.43, 1.35)
Edelman (1999) I = 43
C = 49
Breast, metastatic 50 ± 8.5 70.5 CBT Group 50 6 mo 5 y 1.32 (0.84, 2.08)
McCorkle (2000) I = 190
C = 185
Various types in various stages ≥65 = 66% 65.1 Supportive Individual 12 4 wk 4 y 0.49 (0.32, 0.74)
Goodwin (2001) I = 158
C = 77
Breast, metastatic 49.5 ± 10.3 71.6 SEGT Group 78 1 y 7 y 1.23 (0.88, 1.72)
Kuchler (2007) I = 136
C = 135
Gastrointestinal in various stages 56.8 ± 10.6 71.2 Psychoeducational Individual ≥ every second day During hospital stay 10 y 0.69 (0.52, 0.92)
Spiegel (2007) I = 64
C = 61
Breast, metastatic 53.1 ± 10.6 57 SEGT Group 78 1 y 14 y 0.93 (0.62, 1.40)
Andersen (2008) I = 114
C = 113
Breast, stage II and III ≥ 50 = 51% 73.5 CBT Group 39 1 y 11 y 0.44 (0.22, 0.86)
Bakitas (2009) I = 161
C = 161
Various types with approximately 1 y 64.7 ± 10.8 65.2 Psychoeducational Group ≥43 36 mo 15 mo 0.67 (0.50, 0.91)
Ross (2009) I = 125
C = 124
Colorectal in different stages 68.8 60.5 Supportive Individual 15 10 visits 8 y 0.68 (0.42, 1.09)
Temel (2010) I = 77
C = 74
Non‐small‐cell lung, metastatic 64.9 ± 9.7 61.5 Supportive Individual Till the end 12 wk 6 mo 0.58 (0.40, 0.87)
Stagl (2015) I = 120
C = 120
Breast, 0‐IIIB 49.7 ± 9.0 62.5 CBT Group 15 10 wk 11 y 0.21 (0.05, 0.93)

C, control group; CBT, cognitive‐behavioral therapy; I, intervention group; SEGT, supportive‐expressive group therapy.